Bank of America’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-19,286
| Closed | -$3.38K | – | 7516 |
|
|
2022
Q4 | $3.38K | Buy |
19,286
+16,079
| +501% | +$2.81K | ﹤0.01% | 6310 |
|
|
2022
Q3 | $1K | Sell |
3,207
-208,344
| -98% | -$65K | ﹤0.01% | 6857 |
|
|
2022
Q2 | $180K | Buy |
211,551
+79,754
| +61% | +$67.9K | ﹤0.01% | 5408 |
|
|
2022
Q1 | $726K | Buy |
131,797
+69,073
| +110% | +$380K | ﹤0.01% | 4838 |
|
|
2021
Q4 | $607K | Buy |
62,724
+21,268
| +51% | +$206K | ﹤0.01% | 4944 |
|
|
2021
Q3 | $741K | Buy |
41,456
+25,685
| +163% | +$459K | ﹤0.01% | 4572 |
|
|
2021
Q2 | $384K | Sell |
15,771
-1,587
| -9% | -$38.6K | ﹤0.01% | 4895 |
|
|
2021
Q1 | $460K | Sell |
17,358
-8,513
| -33% | -$226K | ﹤0.01% | 4821 |
|
|
2020
Q4 | $197K | Buy |
25,871
+3,468
| +15% | +$26.4K | ﹤0.01% | 4894 |
|
|
2020
Q3 | $112K | Buy |
22,403
+4,678
| +26% | +$23.4K | ﹤0.01% | 5012 |
|
|
2020
Q2 | $106K | Buy |
17,725
+3,272
| +23% | +$19.6K | ﹤0.01% | 5076 |
|
|
2020
Q1 | $65K | Sell |
14,453
-2,871
| -17% | -$12.9K | ﹤0.01% | 5171 |
|
|
2019
Q4 | $164K | Sell |
17,324
-9,352
| -35% | -$88.5K | ﹤0.01% | 4954 |
|
|
2019
Q3 | $209K | Buy |
26,676
+4,333
| +19% | +$33.9K | ﹤0.01% | 4863 |
|
|
2019
Q2 | $351K | Buy |
22,343
+15,240
| +215% | +$239K | ﹤0.01% | 4580 |
|
|
2019
Q1 | $128K | Sell |
7,103
-3,945
| -36% | -$71.1K | ﹤0.01% | 5001 |
|
|
2018
Q4 | $178K | Buy |
11,048
+9,473
| +601% | +$153K | ﹤0.01% | 4876 |
|
|
2018
Q3 | $38K | Buy |
+1,575
| New | +$38K | ﹤0.01% | 5580 |
|